A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study

Boyko, Alexey; Correale, Jorge; Edan, Gilles; Freedman, Mark S; Giovannoni, Gavin; Montalban, Xavier

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Boyko, Alexey
dc.contributor.author	Correale, Jorge
dc.contributor.author	Edan, Gilles
dc.contributor.author	Freedman, Mark S
dc.contributor.author	Giovannoni, Gavin
dc.contributor.author	Montalban, Xavier
dc.date.accessioned	2023-12-19T09:18:47Z
dc.date.available	2023-12-19T09:18:47Z
dc.date.issued	2023-10
dc.identifier.citation	Giovannoni G, Boyko A, Correale J, Edan G, Freedman MS, Montalban X, et al. A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study. Neurodegener Dis Manag. 2023 Oct;13(5):261–8.
dc.identifier.issn	1479-6694
dc.identifier.uri	https://hdl.handle.net/11351/10717
dc.description	Cladribina; Esclerosi múltiple; Recaigudes
dc.language.iso	eng
dc.publisher	Future Medicine
dc.relation.ispartofseries	Neurodegenerative Disease Management;13(5)
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Esclerosi múltiple - Tractament
dc.subject	Medicaments immunosupressors - Ús terapèutic
dc.subject.mesh	Multiple Sclerosis
dc.subject.mesh	Immunosuppressive Agents
dc.title	A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.2217/nmt-2023-0018
dc.subject.decs	esclerosis múltiple
dc.subject.decs	inmunosupresores
dc.relation.publishversion	https://doi.org/10.2217/nmt-2023-0018
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Giovannoni G] Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. [Boyko A] Pirogov Russian National Research Medical University, Department of Neurology, Neurosurgery and Medical Genetics, Federal Center of Brain Research and Neurotechnologies, Moscow, Russia. [Correale J] Department of Neurology, FLENI Institute, Buenos Aires, Argentina. [Edan G] Department of Neurology, University Hospital of Rennes, Rennes, France. [Freedman MS] University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute, Ottawa, ON, Canada. [Montalban X] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid	37535336
dc.identifier.wos	001042183200001
dc.rights.accessrights	info:eu-repo/semantics/openAccess